Insmed
INSM
#1009
Rank
S$30.28 B
Marketcap
S$139.72
Share price
-5.60%
Change (1 day)
60.11%
Change (1 year)

Insmed (INSM) Fails to deliver data

Key failure to deliver metrics for Insmed:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Insmed (INSM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Insmed (INSM) - since 2013

Volume in USD (price x number of shares), data since 2013

Insmed (INSM) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$23.35 M-60.92%
2025S$59.76 M49.48%
2024S$39.98 M264.99%
2023S$10.95 M15.72%
2022S$9.46 M-28.5%
2021S$13.23 M29.75%
2020S$10.2 M-74.29%
2019S$39.68 M48.24%
2018S$26.76 M204.1%
2017S$8.8 M123.23%
2016S$3.94 M-32.13%
2015S$5.8 M-38.86%
2014S$9.5 M211.03%
2013S$3.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novartis
NVS
S$0.27 BS$0.38 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
S$33.01 MS$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$53.89 MS$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$9.26 MS$25.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/AS$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S$16.61 MS$57.34 M๐Ÿ‡บ๐Ÿ‡ธ USA